What Studies Compare Therapy Intensity for Autism?
Understanding whether “more hours” of therapy lead to better outcomes for autistic children has been a long-standing debate. Evidence from NICE, NHS, Cochrane and recent meta-analyses shows that while some intensive programmes lead to short-term gains, the relationship between therapy intensity and outcomes is far from straightforward.
What NICE and NHS Say About Therapy Intensity
NICE CG170 states that there is insufficient evidence to recommend any one psychosocial intervention over another and does not set hour thresholds for therapy. It emphasises coordinated care, functional skills and adaptive outcomes rather than intensity.
Similarly, NICE CG142 focuses on need-based support, not specific dosage, and NICE QS51 highlights that evidence on different intervention models including intensity and duration, is still developing.
NHS England notes that some interventions require many hours per week and can place emotional and financial strain on families, but it does not recommend specific hourly dosages. NHS guidance instead focuses on early, tailored support for communication, behaviour and daily living.
What Cochrane Reviews Show About Intensity
The Cochrane review on Early Intensive Behavioural Intervention (EIBI) defines (EIBI) as 20–40 hours per week for one to four years. It reports weak, low-certainty evidence of short-term improvements in IQ and adaptive behaviour but identifies no reliable dose–response data.
The NIHR HTA review similarly concludes that evidence on intensity is mixed, of low quality and does not allow firm conclusions about optimal hours.
What Large Meta-Analyses Say About Intervention Amount
The most rigorous analysis comes from the 2024 JAMA Pediatrics meta-analysis, which examined intensity across behavioural, developmental, NDBIs, parent-mediated and technology-based interventions. It found no robust evidence that increasing hours per week, total hours or duration leads to larger effect sizes once study quality is controlled.
This challenges the common assumption that “20–40 hours are best.” The analysis suggests that quality, developmental fitness, and family context may matter more than raw intensity.
Earlier reviews, such as Virués-Ortega’s ABA meta-analysis, suggested benefits from higher hours, but these findings came from non-randomised studies and are now considered highly confounded.
Direct Comparisons and Dose–Response Studies
Most trials compare intensive programmes with much less intensive community services, rather than testing different intensities of the same therapy. (EIBI) studies in the Cochrane evidence did not randomise children to 20 versus 40 hours.
NDBIs trials also confound intensity with intervention type. Observational dose–response analyses exist, but authors note that children who receive more hours often differ in baseline ability and family resources.
What Low-Intensity Trials Tell Us
The long-term follow-up of PACT shows durable reductions in autism symptom severity six years after a relatively low-intensity, parent-mediated intervention. This demonstrates that meaningful long-term benefits do not require very high weekly hours of therapy.
Takeaway
Across high-quality evidence, intensive programmes can support short-term gains, but “more hours” do not reliably predict better outcomes. Current research shows weak or inconsistent dose–response patterns, and guidelines emphasise individualised, developmentally appropriate, family-centred support over fixed intensity targets.
